1Medina J,Fernandez-Salazar LI,Garcia-Buey L,et al.Approach to the papathogenesis and treatment of nonalcobolic steatohep-atitia[J].Diabetes care,2004,27(8):2057-2066.
2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量：1513
5Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD single topic conference[J].Hepatology,2003,37 (5):1202-1209.
6Thamer C,Machann J,Haap M,et al,Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects[J].Diabetes Care,2004,27(11):2726-2729.
7Diehl AM,Li ZP,Lin HZ,et al.Cytokines and the pathogenesis of non-alcoholic steatohepatitis[J].Gut,2005,54 (2):303-306.
8Kelley DE,McKolanis TM,Hegazi RA,et al.Fatty liver in type 2diabetes mellitus:relation to regional adiposity,fatty acids,and insulin resistance[J].Am J Physiol Endocrinol Metab,2003,285(4):906-916.
5Lattuada G, Ragogna F, Perseghin G. Why does NAFLD pre- dict type 2 diabetes [ J ]. Curr Diab Rep, 2011,11 ( 3 ) : 167 - 172.
6Braunwald E,Antrnan EM,Beasley JW,et al. ACC/AHA 2(D2 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-- summary article:a report of the American College of Cardiolo-gy/American Heart Association task force on practice guide- lines( Committee on the Management of Patients with Unstable Angina) [J].J Am Coil Cardiol,2002,d0(7):1 366-1 374.
